Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering (original) (raw)
John Kjekshus2000, The American Journal of Cardiology
visibility
…
description
6 pages
link
1 file
Sign up for access to the world's latest research.
checkGet notified about relevant papers
checkSave papers to use in your research
checkJoin the discussion with peers
checkTrack your impact
Related papers
Randomized Dose-Response Study of Rosuvastatin in Japanese Patients With Hypercholesterolemia
Journal of Atherosclerosis and Thrombosis, 2003
Statins: effects beyond cholesterol lowering
Nephrology Dialysis Transplantation, 2001
The American Journal of Cardiology, 2003
American Heart Journal, 2004
Low Cholesterol and Increased Risk
The Lancet, 1989
BMJ, 2006
European Journal of Gastroenterology & Hepatology, 2012
Japanese Heart Journal, 2004
Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients
International Journal of Cardiology, 2013
Comparative evaluation of the effect of statin drugs in Hyperlipidaemic patients
2011
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
Related papers
Saudi Pharmaceutical Journal, 2015
Atorvastatin treatment meets new European recommendations for the treatment of dyslipidemias
Cardiologia Croatica, 2012
Original Reports: Cardiovascular Disease and Risk Factors
2012
A successful physician training program in cholesterol screening and management
Preventive Medicine, 1991
AAOHN Journal, 1990
Secondary prevention of heart disease with statins: Authors' reply
BMJ, 2005
Effectiveness and hazards of case finding for a high cholesterol concentration
BMJ, 1990
American Heart Journal, 2004
Insufficient modification of atherosclerosis risk factors in PAD patients
Advances in Clinical and Experimental Medicine, 2018
An overview of pleiotropic effect of statins in cardiovascular disease
Pharmacy & pharmacology international journal, 2018
The THRombolysis and STatins (THRaST) study
Neurology, 2013
The Global Burden of Cardiovascular Diseases and Risk Factors
Journal of the American College of Cardiology, 2019
Eventos cardiovasculares: um efeito de classe dos inibidores de COX-2
Arquivos Brasileiros de Cardiologia, 2005
Association of BMI, lipid lowering medication, and
Low High-Density Lipoprotein Cholesterol
Drugs, 2003
22nd Clinical Congress Abstracts
Journal of Parenteral and Enteral Nutrition, 1998
Evolocumab e outcome clinici in pazienti con patologia cardiovascolare
L'Endocrinologo, 2017
Journal of the American College of Cardiology, 1999
Atherosclerosis, 2008
British Journal of Clinical Pharmacology, 2006
Treating Hyperlipidemia for the Primary Prevention of Coronary Disease
Archives of internal medicine, 1998
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins
2000
2019
Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial
JNCI Journal of the National Cancer Institute, 2013
Atherosclerosis, 2013
Related topics
RiskMedicineHypercholesterolemiaAgedCoronary heart diseaseNeoplasmsRandomized Clinical TrialCoronary Artery DiseaseLong Term EffectElsevierSimvastatinConfidence IntervalRelative RiskCause of deathCardiovascular medicine and haem...